Researchers Urge More Company-To-Company Collaboration On Clinical Trials
This article was originally published in The Gray Sheet
Executive Summary
With cost and time commitments ballooning for device and drug clinical development, some prominent researchers are pressing for companies with similar products to join together on new FDA pivotal trials rather than go it alone.